Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

503.P1.33 Hematopoiesis - Regulation of Gene Transcription Poster I

Saturday, December 6, 2008: 5:30 PM-7:30 PM
Hall A (Moscone Center)
Down-Regulation of CEBPA Expression Has a Stronger Impact on Myeloid Differentiation in Human Versus Mouse Cells:  Mechanistic Implications for CEBPA Mutations in AML

Gabriela Bernadeta Iwanski, MD1*, Birte Niebuhr2*, Maike Täger, PhD2*, Susanne Roscher2*, Carol Stocking, PhD2* and Jorg Cammenga, MD3

1Department of Hematology - Oncology, University Hospital Hamburg Eppendorf, 20 246 Hamburg, Germany
2Heinrich-Pette-Institut für experimentelle Virologie und Immunologie, 20 251 Hamburg, Germany
3Dept. of Gene Therapy, Lund Strategic Research Center, Lund, Sweden

The GATA-1 Cofactor FOG-1 Recruits NuRD to Promote Normal Erythroid and Megakaryocyte Development and Maintain Lineage Fidelity by Restricting Mast Cell Gene Expression

Gregory D Gregory1*, Yuhuan Wang1*, Wei Hong2*, Annarita Miccio1*, Alexey Bersenev1*, Xiang Yu1*, Hongxin Wang1*, John Choi1*, Suresh Shelat1*, Wei Tong1*, Mortimer Poncz1* and Gerd Blobel1

1Abramson Research Center, Children's Hosp. of Philadelphia, Philadelphia, PA
2Current address: Thomas Jefferson University, Philadelphia, PA

The Cbl E3 Ubiquitin Ligase Negatively Regulates Erythropoiesis through Expression of the Foxo3a Transcription Factor

Terri D Richmond1*, Monica L Bailey1*, Wallace Y Langdon2* and Dwayne Barber1

1Stem Cells & Developmental Biology, Ontario Cancer Institute, Toronto, ON, Canada
2University of Western Australia, Crawley, Australia

Histone Deacetylases Are Essential for Chromatin Condensation and Enucleation in Mammalian Erythroblasts

Peng Ji, MD, PhD*, Francisco J Sánchez-Rivera* and Harvey F. Lodish, PhD

Whitehead Institute for Biomedical Research, Cambridge, MA

Novel Role of the TAL1/SCL Transcription Factor in Murine Monocytopoiesis

Soumyadeep Dey, M.S.1*, David J. Curtis, MD, PhD2, Stephen Jane, MD, PhD3 and Stephen J. Brandt, MD4

1Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN
2Rotary Bone Marrow Rsch. Lab., RMH Research Foundation, Parkville, VIC, Australia
3Royal Melbourne Hospital, Parkville, VIC, Australia
4Vanderbilt Univ. Medical Ctr., Nashville, TN

Distinct Epigenetic Modifications of Hematopoietic Cells Define Undifferentiated Status and Susceptibility to Epigenetic Reprogramming

Il-Hoan Oh, MD, PhD, Yun-Shin Chung*, Tae-Min Kim* and Kyong-Rim Kwon*

Cell Therapy Center, Rsch. Inst. of Med. Science, Seoul, South Korea

HoxB4 Effects on Hematopoietic Stem Cells Are Dependent on STAT3 Activity; A Potential Convergence of Self-Renewing Signals

Seung-Jip Yang1*, Seong-Hyun Hong1*, Ga-Young Lee1*, Ju-Young Jung1* and Il-Hoan Oh, MD, PhD2

1Catholic Cell Therapy Center, The Catholic University of Korea, Seoul, South Korea
2Cell Therapy Center, Rsch. Inst. of Med. Science, Seoul, South Korea

SCL and Associated Proteins Distinguish Active from Repressive GATA Transcription Factor Complexes

Wulan Deng1*, Tamara Tripic, PhD1*, Yong Cheng2*, Ying Zhang2*, Christopher Vakoc, PhD1*, Ross Hardison, PhD2* and Gerd Blobel, MD, PhD1

1Abramson Research Center, Children's Hosp. of Philadelphia, Philadelphia, PA
2Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA

GATA-2 Controls Proliferation of Megakaryocyte Progenitors and Its Expression Contributes to Human DS-AMKL

Zan Huang, PhD1* and John Crispino, PhD2

1Dept Med/Div Hematol&Oncol, Northwestern University, Chicago, IL
2Medicine, Hematology/Oncology, Northwestern University, Chicago, IL

Phosphorylation of Runx1 by Cyclin-Dependent Kinases Regulates Its Interaction with HDAC1 and HDAC3

Hong Guo, M.D., Ph.D.* and Alan D. Friedman, M.D.

Pediatric Oncology, Johns Hopkins University, Baltimore, MD

Bidirectional Control of Transcription Factor GATA2 and Cyclin/Cdks in Hematopoietic Cells

Naoko Minegishi, MD, PhD1, Hideo Harigae, M.D2 and Masayuki Yamamoto, MD, PhD3*

1Health & Welfare Science, Sendai University, Miyagi Prefecture, Japan
2Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan
3Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan

*signifies non-member of ASH